| Paula Pacurari, MD | |
|
2261 Philadelphia Dr Ste 301, Dayton, OH 45406-1814 | |
| (937) 734-4141 | |
| (937) 277-7249 |
| Full Name | Paula Pacurari |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 2261 Philadelphia Dr Ste 301, Dayton, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043848419 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 35.148946 (Ohio) | Primary |
| Entity Name | Mvhe Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659504785 PECOS PAC ID: 9537066584 Enrollment ID: O20031217000553 |
News Archive
If you want to increase your chances of living longer, taking cholesterol drugs is an easy way to do it. That's the message from a Harvard study of 4,162 people hospitalized in 350 places in eight countries. It is the first research to show that intense lowering of cholesterol results in a major reduction in deaths and severe heart attacks.
Escalating costs and lengthy clinical trials are major concerns for researchers attempting to boost productivity and efficiency in the field of drug discovery. Biomarkers are emerging as the solution to these problems with their ability to reduce drug development costs and time.
As physicians and families know too well, though Alzheimer's disease has been intensely studied for decades, too much is still not known about molecular processes in the brain that cause it.
In the United States today, healthcare providers seem appropriately confused about present and future issues concerning coronavirus disease 2019 (COVID-19).
› Verified 6 days ago
| Entity Name | Upper Valley Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407872518 PECOS PAC ID: 5597658138 Enrollment ID: O20040206000038 |
News Archive
If you want to increase your chances of living longer, taking cholesterol drugs is an easy way to do it. That's the message from a Harvard study of 4,162 people hospitalized in 350 places in eight countries. It is the first research to show that intense lowering of cholesterol results in a major reduction in deaths and severe heart attacks.
Escalating costs and lengthy clinical trials are major concerns for researchers attempting to boost productivity and efficiency in the field of drug discovery. Biomarkers are emerging as the solution to these problems with their ability to reduce drug development costs and time.
As physicians and families know too well, though Alzheimer's disease has been intensely studied for decades, too much is still not known about molecular processes in the brain that cause it.
In the United States today, healthcare providers seem appropriately confused about present and future issues concerning coronavirus disease 2019 (COVID-19).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paula Pacurari, MD 2261 Philadelphia Dr Ste 300, Dayton, OH 45406-1814 Ph: (937) 734-4141 | Paula Pacurari, MD 2261 Philadelphia Dr Ste 301, Dayton, OH 45406-1814 Ph: (937) 734-4141 |
News Archive
If you want to increase your chances of living longer, taking cholesterol drugs is an easy way to do it. That's the message from a Harvard study of 4,162 people hospitalized in 350 places in eight countries. It is the first research to show that intense lowering of cholesterol results in a major reduction in deaths and severe heart attacks.
Escalating costs and lengthy clinical trials are major concerns for researchers attempting to boost productivity and efficiency in the field of drug discovery. Biomarkers are emerging as the solution to these problems with their ability to reduce drug development costs and time.
As physicians and families know too well, though Alzheimer's disease has been intensely studied for decades, too much is still not known about molecular processes in the brain that cause it.
In the United States today, healthcare providers seem appropriately confused about present and future issues concerning coronavirus disease 2019 (COVID-19).
› Verified 6 days ago
Dr. Derek Williamson Sherk, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3077 Kettering Blvd, Suite Number 319, Dayton, OH 45439 Phone: 937-293-2133 | |
Dr. Barbara A Bennett, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8701 Troy Pike Ste 50, Dayton, OH 45424 Phone: 937-233-4252 Fax: 937-233-7605 | |
Jeffrey R Millard, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 30 E Apple St, Ste 6250, Dayton, OH 45409 Phone: 937-208-8394 Fax: 937-208-8388 | |
Dr. Teresa Zryd, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 725 University Blvd, Dayton, OH 45435 Phone: 937-245-7200 Fax: 937-245-7922 | |
Dr. Roger N Rizzardi, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1010 Woodman Dr, Dayton, OH 45432 Phone: 937-252-2000 | |
Dr. Robert Randall Schaffer, M.D., FAAFP Family Medicine Medicare: Medicare Enrolled Practice Location: 4100 W 3rd St, Dayton, OH 45428 Phone: 937-268-6511 Fax: 513-423-3309 | |
Theresa Kern, MS,RN, AGCNS-BC Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 324 Wilmington Ave, Dayton, OH 45420 Phone: 937-256-4490 Fax: 937-258-5478 |